Attachment
The next five years from 2009 will see more leading drugs going off patent, thus increasing opportunities for generics producers. Regulations favouring generic products give cause for optimism in the generics sector, while still leaving scope for novel branded drugs. We predict that total revenues in the generics market will continue to increase in the years ahead.
Major players have been moving into the generic drugs market - spearheaded by leading pharma companies and specialist pharma organisations. Established generics companies, such as Teva, are increasing in commercial prominence and international reach. There are many rising challengers in developed and developing countries, inspired by patent expiry on major drugs. What will be the main challenges and the main opportunities in this market from 2009 onwards? The new Visiongain report World Generics Market 2009-2024 investigates such questions in depth.
This report reveals forecasted sales in the world generics market and in leading national markets, providing detailed quantitative and qualitative data. In particular World Generics Market 2009-2024 includes generics market forecasts for:
* The US
* Europe (with special focus on Germany, France, the UK, Italy and Spain)
* Japan
* China
* India
* Russia
Visiongain: World Generics Market 2009-2024:
http://www.reports-
Visiongain: More market data and market reports:
http://www.reports-
Photo:
http://www.prlog.org/
